menu
    • menu

    Company profile for Orbicular Pharmaceutical Technologies

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orbicular Pharmaceutical Technologies Pvt. Ltd. is a research oriented pharmaceutical product development company with proven capabilities across various dosage forms. Our business strategy revolves around developing niche generic and specialty pharmaceutical products and licensing them at late stages to our global partners. The company ambitious strategic plan is to execute the defined CI-TOP SPIN Strategy for both Regulated ...
    Orbicular Pharmaceutical Technologies Pvt. Ltd. is a research oriented pharmaceutical product development company with proven capabilities across various dosage forms. Our business strategy revolves around developing niche generic and specialty pharmaceutical products and licensing them at late stages to our global partners. The company ambitious strategic plan is to execute the defined CI-TOP SPIN Strategy for both Regulated and Emerging Markets. CI-TOP SPIN basically refers to Complex Injectables, Topicals , Ophthalmic, Parenterals, Nasal Sprays and Inhalations which characterizes a product domain.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orbicular Pharmaceutical Technologiesindia-flag Flag
    Country
    Country
    India
    Address
    Address
    P. No. 53, ALEAP Industrial Estate, Behind Pragati Nagar, Kukatpally, Hyderaba...
    Telephone
    Telephone
    +91 8978015432
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://orbicular.co.in/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/orbicular-pharmaceutical-technologies-pvt.ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/orbicular

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onesource And Orbicular Secure USFDA Tentative Approval
    Onesource And Orbicular Secure USFDA Tentative Approval

    21 Apr 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/onesource-and-orbicular-secure-usfda-tentative-approval-for-generic-semaglutide-injection/

    EXPRESSPHARMA
    21 Apr 2026
    Share Share
    Orbicular, Gland Pharma, Apotex Obtain US FDA Approval
    Orbicular, Gland Pharma, Apotex Obtain US FDA Approval

    15 Apr 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/orbicular-gland-pharma-and-apotex-secure-us-fda-approval-for-generic-infuvite-adult-injectable/

    EXPRESSPHARMA
    15 Apr 2026
    Share Share
    Apotex Secures FDA Approval For Generic Infuvite Adult
    Apotex Secures FDA Approval For Generic Infuvite Adult

    14 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apotex-announces-fda-approval-of-first-generic-infuvite-adult-injection-single-dose-vial-and-pharmacy-bulk-package-with-180day-cgt-exclusivity-for-the-pharmacy-bulk-package-in-partnership-with-orbicular-and-gland-pharma-302741788.html

    PR NEWSWIRE
    14 Apr 2026
    Share Share
    Orbicular’s Generics Phytonadione Receives Approval in US
    Orbicular’s Generics Phytonadione Receives Approval in US

    13 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216298

    FDA
    13 Mar 2026
    Share Share
    Orbicular’s Generics Liraglutide Receives Approval in US
    Orbicular’s Generics Liraglutide Receives Approval in US

    24 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217234

    FDA
    24 Feb 2026
    Share Share
    Orbicular’s Generics Liraglutide Receives Approval in US
    Orbicular’s Generics Liraglutide Receives Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217590

    FDA
    14 Jan 2026
    Share Share

    Services

    Upload your portfolio for free, ask us

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search